Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-21

Clinical Trial Update: Minocycline and Tobacco Craving in Smokers With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing minocycline for tobacco craving in smokers with schizophrenia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Tobacco Use | Phase 4 | Status: COMPLETED | Results posted: 2021-10-21